Divis Labs Limited. Q4 results show a revenue rise from 1821.93 to 2016.92 crores, a 10.70% increase in growth. EPS also rise from ₹11.56 to ₹12.09, up by 4.58%.
First, Let’s Begin with Quarter-on-Quarter Basis:
Divis Labs Ltd. shared its Q4 results on Saturday. They earned 2016.92 crores in revenue this quarter, but that’s higher than the 1821.93 crores they made last quarter. The company’s growth increased by 10.70 percent when comparing the two quarters.
In terms of profits, Divis Labs Ltd’s PAT (Profit After Tax) for this quarter was 320.97 crores, up from 306.80 crores in the previous quarter. Their quarter-to-quarter growth inclined by 4.62 percent.
The company’s EPS (Earnings Per Share) this quarter is ₹12.09, which is an increase of 4.58% from the ₹11.56 EPS in the previous quarter.
Also read: ☞ ” NTPC Q4FY23 Results: Consolidated PAT Rise at Rs 4860.67 Cr “
Now, Let’s Analyze the Results on a Year-over-Year Basis:
The company made a total revenue of 8112.17 crores this year (2023), which is 10.60 percent lower than last year’s total revenue of 9073.70 crores.
This year’s PAT (Profit After Tax) is 1823.38 crores, which is also 38.41% lower than last year’s PAT of 2960.45 crores.
The EPS (Earnings Per Share) for this year is ₹68.69, which is 38.41% less than the EPS of ₹111.52 earned last year.
Divis Labs Share Dividend Announcement / Record Date:
The Board of Directors has declared a Final Dividend of ₹30 per Equity Share of Face Value of ₹2 each of the Company (1500% of Face Value). Total Dividend for FY23 stood at ₹30 per Equity Share (Interim Dividend of ₹2 per Equity Share)
| Dividend | Record Date |
| ₹30 per Equity Share | Coming Soon |
The record date for the dividend has not arrived yet.
About Divis Labs:
Divi’s Laboratories Limited is a multinational pharmaceutical company based in Hyderabad, India. It is known for its production of active pharmaceutical ingredients (APIs) and intermediates. The company specializes in manufacturing and custom synthesis of generic APIs and intermediates.
Download Full PDF Q4 Results of Divis Labs: Click Here
For more of the Latest News, Click Here
One thought on “Divis Labs Q4FY23 Results: Consolidated PAT Rise to Rs 320.97 Cr”